BIOGEN INC.

(BIIB)
  Rapport
Vertraagde tijd Nasdaq  -  22:00 12-08-2022
220.99 USD   +1.27%
26/07Biogen zegt dat Amerikaanse FDA NDA aanvaardt en prioritaire beoordeling toekent voor geneesmiddel tegen Amyotrofische Lateraal Sclerose
MT
26/07Biogen zegt dat Amerikaanse FDA NDA aanvaardt en prioritaire beoordeling toekent voor geneesmiddel tegen Amyotrofische Lateraal Sclerose
MT
26/07Amerikaanse FDA geeft prioriteit aan beoordeling van Biogen's ALS-medicijn
MR
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op BIOGEN INC.
12/08Novartis bestätigt Todesfälle nach Behandlung mit Gentherapie
12/08Novartis confirme deux décès liés à sa thérapie génique Zolgensma
12/08Novartis bestätigt Todesfälle nach Behandlung mit Gentherapie Zolgensma
04/08El fármaco contra el Alzheimer de Lilly podría obtener una rápida aprobación de la FDA ..
04/08Eisai presents new findings on lecanemab's investigational subcutaneous formulation and..
28/07The New England Journal of Medicine Publishes Positive Phase 2 Data on Litifilimab (BII..
28/07The New England Journal of Medicine Publishes Positive Phase 2 Data on Litifilimab (BII..
27/07Biogen Inc. - FDA Accepts Biogen's New Drug Application and Grants Priority Review of T..
26/07Biogen Says US FDA Accepts NDA, Grants Priority Review for Amyotrophic Lateral Sclerosi..
26/07Biogen Says US FDA Accepts NDA, Grants Priority Review for Amyotrophic Lateral Sclerosi..
26/07U.S. FDA accepts Biogen's ALS therapy for review
26/07U.S. FDA grants priority review to Biogen's ALS drug
26/07FDA Accepts Biogen's New Drug Application and Grants Priority Review of Tofersen for a ..
26/07Biogen Inc. Announces FDA Accepts its New Drug Application and Grants Priority Review o..
26/07Biogen Gets FDA Priority Review of Tofersen in Rare Form of ALS
25/07Novartis-Tochter Sandoz kommt mit Antrag für MS-Biosimilar voran
25/07NOVARTIS : demande d'homologation évaluée pour natalizumab de Sandoz
21/07Growth stocks are back in favor
21/07USA-Les valeurs à suivre à Wall Street (actualisé)
21/07ANALYST RECOMMENDATIONS : Tesla, Nike, Netflix, Idexx Laboratories, Biogen...
21/07WALL STREET : rebond prolongé, même sans catalyseurs
20/07US Stocks Close Higher Wednesday, Led by Consumer Discretionary, Tech
20/07BIOGEN INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF..
20/07US Stocks Close Higher Wednesday Despite Steeper-Than-Expected Existing-Home Sales Decl..
20/07Biogen Faces Declining Sequential Revenue Despite Positive Q2 Results, Wedbush Says
20/07Health Care Down as Biogen, Merck Retreat -- Health Care Roundup
20/07BIOGEN : Reports Second Quarter 2022 Results - Form 8-K/A
20/07Biogen Shares Decline After Company Reports Lower Q2 Profits, Revenue
20/07Investors take a wait-and-see attitude ahead of central bank meetings
20/07Les valeurs à suivre aujourd'hui à Wall Street - Mercredi 20 juillet 2022
20/07Biogen chops expenses in Q2, raises 2022 profit forecast
20/07Biogen double son bénéfice par rapport au premier trimestre
20/07AKTIEN NEW YORK AUSBLICK : Knappe Verluste erwartet - Netflix überzeugt
20/07Biogen says aiming to build commercial infrastructure for alzhei…
20/07BIOGEN : relèvement des objectifs pour 2022
20/07Pharmakonzern Biogen erhöht Jahresziele - Zweites Quartal besser als befürchtet
20/07Biogen says co continues to enforce its patents, but biosimilar…
20/07Biogen says partner eisai plans to file for traditional approval…
20/07TRANSCRIPT : Biogen Inc., Q2 2022 Earnings Call, Jul 20, 2022
20/07Biogen Reports Lower Q2 Profits, Revenue
20/07BIOGEN : Reports Second Quarter 2022 Results 582.7 KB
20/07BIOGEN : Reports Second Quarter 2022 Results
20/07BIOGEN : Reports Second Quarter 2022 Results - Form 8-K
20/07Biogen leans on new Alzheimer's drug to calm investor worries
20/07Biogen profit more than doubles on Samsung Bioepis stake sale
20/07BIOGEN : Q2 2022 Biogen Earnings Presentation
20/07BIOGEN : Reports Q2 2022 Earnings
20/07Biogen Inc. Updates Earnings Guidance for Full Year 2022
20/07Biogen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 3..
20/07Tranche Update on Biogen Inc.'s Equity Buyback Plan announced on October 21, 2020.
20/07USA-Les valeurs à suivre à Wall Street (actualisé)
20/07MARKETMIND : Weapons of war
20/07Reuters-schedule/…
18/07GLOBAL MARKETS LIVE : Boeing, Gazprom, HSBC, Bank of America, Goldman Sachs...
18/07The calm before the storm?
18/07USA-Les valeurs à suivre à Wall Street (actualisé)
07/07Japan Index Recuperates; V Cube Shares Rally 5%
06/07BIOGEN : to Report Second Quarter 2022 Financial Results July 20, 2022
06/07Eisai Co., Ltd. - THE U.S. FDA ACCEPTS AND GRANTS PRIORITY REVIEW FOR EISAI'S BIOLOGICS..
06/07Biogen, Eisai Get FDA Priority Review for Alzheimer's Treatment Lecanemab
06/07Eisai Gets US Priority Review for Alzheimer's Drug
06/07Japan's Nikkei falls on slowdown worries, energy losses
06/07Japanese shares fall on energy rout, economic slowdown fears
06/07Eisai Shares Rise Sharply After U.S. FDA Grants Priority Review for Potential Alzheimer..
06/07The u.s. fda accepts and grants priority review for eisai's biologics license applicati..
06/07Eisai Co., Ltd. and Biogen Inc. Announces U.S. Food and Drug Administration Accepted th..
03/07Les multinationales américaines aux prises avec l'envolée du dollar
24/06Biogen Terminates Alzheimer's Drug Aduhelm Study Over Coverage Limits
24/06BIOGEN INC.(NASDAQGS : BIIB) added to Russell Midcap Value Index
24/06BIOGEN INC.(NASDAQGS : BIIB) dropped from Russell Top 200 Value Index
24/06BIOGEN INC.(NASDAQGS : BIIB) dropped from Russell Top 200 Index
24/06BIOGEN INC.(NASDAQGS : BIIB) added to Russell Midcap Index
22/06Biogen, Happify Health Team Up to Offer Digital Services for Multiple Sclerosis Patient..
22/06Biogen Inc. - European Patent Office Grants Patent Related to TECFIDERA (Dimethyl Fumar..
22/06Biogen and Happify Health Collaborate to Support Multiple Sclerosis Patients on Digital..
1  2  3  4  5  6  7  8  9  10Volgende
Volgende evenement op BIOGEN INC.